seeking seed funding/ commercialisation of trans dermal dd- microneedle technology

Sir/Madam,

We at Zeopane have developed a new and innovative drug-delivery technology called zeolite micro-needles that is superior to the conventional technologies being used currently. Micro-needles are believed to be the drug-delivery mechanism of choice for the future. While there are several microneedle technologies in different stages of development, ours is far superior to the others because of the nature of the material used. We have an innovative drug-delivery  technology that we've designed using our R&D expertise in zeolite-based nano structures. We've validated the technology in in-vitro trials already and will be soon moving into pre-clinical trials with insulin and Low-molecular weight heparin as drugs.

Published Patent covers the production of micro needles using a unique material that provides increased safety (no infections) and mechanical strength (to ensure penetration and reduce breakage risks) and a unique process of manufacturing these microneedles 

Applicator - Core technology is solid and hollow micro needles that will deliver drugs based on diffusion by penetrating the first two layers of the skin and ensuring efficient delivery. This technology can be used in applications such as transdermal patches, pen-injectors (similar to insulin pens) and catheters.

We are a company whose research team has expertise on production of these micro needles. We do not have as much expertise on commercialization of medical technologies. We see that you have an expertise in this area of transdermal drug-delivery. So, we would like to have a proposal from you on (commercialization assistance, clinical trials assistance, product design and manufacturing experience) you can provide. 

With regards,

Mukesh Mehta 
VP- Business dev.

www.zeopane.com